161615-21-0
Chemical Structure
2’-O-Acetyl-3’,5’-bis-O-benzoyl-6-aza-xylo uridine
- CAS No.: 161615-21-0
- Formula:C24H21N3O9
- Molecular Weight:495.44
IUPAC Name: (2R,3S,4R,5R)-4-acetoxy-2-((benzoyloxy)methyl)-5-(3,5-dioxo-4,5-dihydro-1,2,4-triazin-2(3H)-yl)tetrahydrofuran-3-yl benzoate
InChIKey: MHIQMVXETCFLAQ-GFOJFJKKSA-N
SMILES: O=C(C=N1)NC(N1[C@@H]2O[C@H](COC(C3=CC=CC=C3)=O)[C@H](OC(C4=CC=CC=C4)=O)[C@H]2OC(C)=O)=O
Biological Activity: 2’-O-Acetyl-3’,5’-bis-O-benzoyl-6-aza-xylo uridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
2’-O-Acetyl-3’,5’-bis-O-benzoyl-6-aza-xylo uridine | 2’-O-Acetyl-3’,5’-bis-O-benzoyl-6-aza-xylo uridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
